Iradimed

Iradimed

IRMD· Manufacturing· Fiscal year ends in December

CEO pay in FY2025Stock +76.9% in FY2025

Roger Susi is the CEO of Iradimed and was paid $780.6K in FY2025 (Dec), up 13%.

Pay$100 in the stock at the end of FY21 → $215
CEO pay is from each Iradimed proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Executives3

See all
  1. 1Roger SusiFY2025
  2. 2John GlennFY2025
  3. 3Jeffrey ChiprinFY2025

Named executives and their total pay, from the Summary Compensation Table of the latest proxy.

Pay

See all

Iradimed paid its 3 named executives $1.9M in total in FY2025 (Dec). CEO Roger Susi was paid $780.6K of that.

Name
Roger SusiPresident and Chief Executive Officer
John GlennChief Financial Officer
Jeffrey ChiprinChief Commercial Officer

of each named executive, from the Summary Compensation Table of each proxy.

Peers

No disclosed peer group

No proxy on file names a pay peer group for Iradimed. The peer group comes from the proxy statement, so it shows here when a proxy read has it.

Activity

Filings6

See all
Proxy statementDEF 14AApr 30, 2026FY2025
Annual report10-KMar 6, 2026FY2025
Proxy statementDEF 14AApr 30, 2025FY2024
Annual report10-KMar 6, 2025FY2024
Proxy statementDEF 14AApr 29, 2024FY2023
Annual report10-KMar 1, 2024FY2023
For the press:Download CSVDownload PNGHow to use our data